Natera, Inc. Profile Avatar - Palmy Investing

Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 3 3 LDA-2 Oct. 17, 2024, 2:39 p.m.
2024 2 3 LDA-2 July 18, 2024, 7:23 p.m.
2024 1 3 LDA-2 April 15, 2024, 5:55 p.m.
2023 4 2 LDA-2 Jan. 23, 2024, 8:29 p.m.
End of NTRA's Analysis
CIK: 1604821 CUSIP: 632307104 ISIN: US6323071042 LEI: - UEI: -
Secondary Listings
NTRA has no secondary listings inside our databases.